Log In
BCIQ
Print this Print this
 

Alpharen, fermagate

  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionCalcium-free non-absorbed phosphate binder
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationHyperphosphatemia
Indication DetailsTreat hyperphosphatemia in adult patients with stage 5 chronic kidney disease (CKD) receiving dialysis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today